|
KMID : 0370220170610010055
|
|
Yakhak Hoeji
2017 Volume.61 No. 1 p.55 ~ p.63
|
|
|
An Overview and Suggestions of the Post-listing Control System for Pharmaceutical Pricing in K
|
|
Kang Ye-Rim
Ko So-Hee
Lee Jong-Hyuk
|
|
|
Abstract
|
|
|
|
This study examines post-listing control systems for pharmaceutical pricing and suggests a reasonable improvement policy in Korea. There are four post-listing control systems for pharmaceutical pricing in Korean national health insurance. When each scheme was introduced, they had their own background and goals. But it is very difficult to understand and predict the timing and extent of the price cuts due to complex system by introducing or revising some schemes without clear policy objectives. At the same time, the social costs are often caused by various confusions, including distribution sites, due to frequent price cuts. For this reason, the current post-listing control system needs to be improved. We investigated the latest trends of the post-listing control system of the major countries that operate a similar system through literatures, website, reports of relevant institutions. From a mid- to long-term point of view, the system should be that can enhance the health of the population by comprehensively reflecting drug prescribing behavior and use status under clear target for drug expenditure management. It should also be developed as a system that can create a healthy industrial ecosystem for the development of the pharmaceutical industry.
|
|
|
KEYWORD
|
|
|
post-listing control system, pharmaceutical pricing, price cut, national health insurance
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|